United Kingdom Ulcerative Colitis Market Trends

• Shift towards biologics from generics: The United Kingdom ulcerative colitis market has witnessed a noticeable shift from traditional generics drugs to novel biologics therapies in recent years. Several biologics drugs that target specific proteins or molecules involved in the inflammation process of ulcerative colitis have become very popular treatment options among patients and physicians. These biologics drugs, such as Humira, Stelara, and Entyvio, have demonstrated high rates of induction and maintenance of remission compared to generic medications in clinical trials. As a result, the prescriptions and sales volumes of these biologics drugs have grown significantly over the forecast period.

Figure 1.  United Kingdom Ulcerative Colitis Market Value (US$ Mn), By Region, 2023